≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Transient synovitis

DOID EFO Endpoint Browser PheWeb

M13_TRANSSYNOVITIS

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — M67.3
  • Cause of death: ICD-10 — M67.3

2 out of 7 registries used, show all original rules.

328

4. Check minimum number of events

None

328

5. Include endpoints

None

328

6. Filter based on genotype QC (FinnGen only)

328

Control definitions (FinnGen only)

Control exclude
M13_SOFTTISSUE

Extra metadata

Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
M67
Name in latin
Synovitis transitoria

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 4739 1722 3013
Only index persons 3886 1464 2422
Unadjusted period prevalence (%)
Whole population 0.07 0.05 0.08
Only index persons 0.08 0.05 0.09
Median age at first event (years)
Whole population 6.89 8.17 6.11
Only index persons 8.02 10.50 6.51

-FinnGen-

Key figures

All Female Male
Number of individuals 328 191 137
Unadjusted period prevalence (%) 0.06 0.07 0.06
Median age at first event (years) 23.78 30.04 15.06

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
286
Matched controls
2859
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
M67.3
ICD-10 Finland
Transient synovitis
+∞
323.0
286
*
M67.4
ICD-10 Finland
Ganglion
31.6
31.2
41
15
M25.5
ICD-10 Finland
Pain in joint
4.9
28.3
112
330
NDM40
NOMESCO Finland
Discission of sheath of tendon of wrist or hand
+∞
20.0
19
*
M65.3
ICD-10 Finland
Trigger finger
27.6
17.2
23
9
NDM20
NOMESCO Finland
Excision of synovial ganglion of wrist or hand
180.1
16.7
17
*
M13.9
ICD-10 Finland
Arthritis, unspecified
7.8
16.3
38
55
NBG15
NOMESCO Finland
Acromioplastia, arthroscopic
40.5
15.6
19
5
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
4.8
13.9
48
115
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
13.0
13.9
24
20
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
5.3
13.2
41
87
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
6.2
12.9
35
63
M79.6
ICD-10 Finland
Pain in limb
3.0
12.8
86
355
NGA30
NOMESCO Finland
Exploration of knee joint, arthroscopic
10.0
12.8
25
27
NGF15
NOMESCO Finland
Total synovectomy of knee, arthroscopic
45.2
11.0
13
*
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
9.1
10.8
22
26
N06AA09
ATC
amitriptyline; systemic
6.4
10.7
28
48
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
5.4
10.7
32
65
M65.9
ICD-10 Finland
Synovitis and tenosynovitis, unspecified
16.9
10.5
16
10
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
9.4
10.5
21
24
M01AH05
ATC
etoricoxib; oral
2.3
10.3
143
867
M19.0
ICD-10 Finland
Primary arthrosis of other joints
6.5
10.3
26
43
NGF00
NOMESCO Finland
Excision of plica of synovy of knee
12.8
10.0
17
14
NGF35
NOMESCO Finland
Plastic operation of joint cartilage of knee
10.6
9.7
18
18
M17.1
ICD-10 Finland
Other primary gonarthrosis
3.6
9.6
44
137
M75.1
ICD-10 Finland
Rotator cuff syndrome
3.7
9.3
41
123
M02AA07
ATC
piroxicam; topical
2.5
9.0
79
375
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
7.2
9.0
21
31
M75.4
ICD-10 Finland
Impingement syndrome of shoulder
11.2
8.9
16
15
N02AX02
ATC
tramadol; systemic, rectal
2.4
8.9
88
444
M65.8
ICD-10 Finland
Other synovitis and tenosynovitis
16.9
8.6
13
8
NGF25
NOMESCO Finland
Operation for osteochondritis of knee, arthroscopic
5.5
8.1
23
45
N02AJ06
ATC
codeine and paracetamol; systemic
2.2
7.9
92
500
A07EC01
ATC
sulfasalazine; oral, rectal
4.0
7.9
31
85
M01AC06
ATC
meloxicam; systemic, rectal
2.4
7.9
77
386
SPAT1153
SPAT
Removal of sutures
2.4
7.6
73
362
L88
ICPC
Rheumatoid/seropositive arthritis
6.8
7.5
18
28
P01BA02
ATC
hydroxychloroquine; oral
4.4
7.4
26
64
L04AA13
ATC
leflunomide; oral
11.3
7.4
13
12
G56.0
ICD-10 Finland
Carpal tunnel syndrome
3.5
7.2
32
98
N06AX21
ATC
duloxetine; oral
3.7
7.0
29
84
ZXA00
NOMESCO Finland
Right side
2.5
7.0
60
279
NF1AA
NOMESCO Finland
Hip X-ray examination
4.8
6.9
22
49
M01AE02
ATC
naproxen; oral, rectal
1.9
6.9
171
1242
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
3.3
6.6
32
105
M23.8
ICD-10 Finland
Other internal derangements of knee
6.0
6.6
17
30
M17.5
ICD-10 Finland
Other secondary gonarthrosis
14.7
6.4
10
7
M08.4
ICD-10 Finland
Pauciarticular juvenile arthritis
11.4
6.3
11
10
M01AH01
ATC
celecoxib; oral (coxibs)
3.0
6.3
36
132
NGF10
NOMESCO Finland
Total synovectomy of knee, open
+∞
6.3
6
*
M17.0
ICD-10 Finland
Primary gonarthrosis, bilateral
3.6
6.1
26
77
R01BA52
ATC
pseudoephedrine, combinations; oral
2.2
6.1
67
349
L15
ICPC
Knee symptom/complaint
2.2
6.0
63
320
M23.2
ICD-10 Finland
Derangement of meniscus due to old tear or injury
3.3
6.0
29
95
M01AX17
ATC
nimesulide; oral
2.6
6.0
42
175

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
21
29
7.67
14.57
2.0
1.4
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
189
1249
2.21
11.08
10.8
5.8
e9/l
2.1
2.0
0.30
174
1097
(3001604) Monocytes [#/volume] in Blood
182
1190
2.19
10.90
10.9
5.9
e9/l
0.6
0.6
0.10
164
1020
(3013115) Eosinophils [#/volume] in Blood
185
1227
2.16
10.57
11.6
6.4
e9/l
0.2
0.2
0.02
170
1072
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
69
301
2.64
10.55
1.3
1.2
u/ml
15.1
12.0
0.08
24
117
(3006315) Basophils [#/volume] in Blood
181
1194
2.15
10.44
11.0
5.9
e9/l
0.0
0.0
0.12
165
1020
(3013707) Erythrocyte sedimentation rate by Westergren method
229
1670
2.23
10.04
6.2
3.4
mm/h
9.7
8.9
0.40
224
1536
(3002030) Lymphocytes/100 leukocytes in Blood
178
1188
2.09
9.71
10.9
6.0
%
31.5
30.8
0.36
170
1126
(3018010) Neutrophils/100 leukocytes in Blood
176
1171
2.09
9.67
10.9
5.8
%
53.8
54.9
0.57
169
1110
(3019069) Monocytes/100 leukocytes in Blood
170
1132
2.04
9.16
11.3
6.3
%
8.3
8.4
0.28
163
1071
(3006504) Eosinophils/100 leukocytes in Blood
168
1121
2.02
8.92
11.2
6.1
%
2.7
2.8
0.26
159
1048
(3021788) Differential panel - Synovial fluid
12
16
7.75
8.46
2.3
1.5
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
162
1084
1.98
8.37
11.4
6.3
%
0.6
0.7
0.87
153
1018
(3013650) Neutrophils [#/volume] in Blood by Automated count
195
1398
1.97
8.16
13.3
8.9
e9/l
3.9
3.9
0.20
179
1198
(3037467) Urinalysis macro (dipstick) panel - Urine
213
1576
2.00
8.12
5.2
3.7
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
124
763
2.01
8.09
9.9
5.9
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
57
270
2.34
7.18
1.4
1.3
titre
511.1
390.0
—
9
52
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
65
326
2.24
7.16
1.3
1.2
iu/ml
29.4
31.6
0.07
17
100
(3013826) Glucose [Moles/volume] in Serum or Plasma
172
1225
1.85
6.91
6.3
4.8
mmol/l
6.5
6.4
0.09
155
1117
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
220
1697
1.90
6.81
7.7
6.4
u/l
80.0
82.1
0.21
211
1582
(40761535) Cells panel - Urine sediment
37
148
2.69
6.63
4.6
3.4
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
157
1113
1.79
6.19
4.9
3.1
estimate
0.0
0.0
0.00
25
214
(3023368) Bacteria identified in Blood by Culture
81
468
1.97
6.09
4.4
3.7
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
157
1126
1.76
5.85
4.9
3.1
estimate
0.0
0.0
0.00
28
213
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
128
867
1.78
5.80
4.4
3.2
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
13
29
4.63
5.56
1.8
1.4
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
89
549
1.85
5.44
5.6
3.2
kg/l
1.0
1.0
0.07
15
79
(3021601) Nitrite [Presence] in Urine by Test strip
153
1114
1.70
5.22
6.1
4.3
estimate
0.0
0.0
0.50
28
226
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
74
453
1.82
4.57
2.9
1.7
mg/l
1.0
1.1
0.20
57
332
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
289
2561
2.08
4.54
16.5
10.0
mg/l
22.4
21.9
0.07
222
1867
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
96
639
1.71
4.43
2.7
2.9
ng/l
14.1
28.1
2.02
57
355
(3029937) Albumin [Presence] in Urine by Test strip
90
592
1.72
4.32
4.9
3.4
estimate
0.0
0.0
0.80
28
214
(3011397) Hemoglobin [Presence] in Urine by Test strip
79
501
1.76
4.32
4.7
3.0
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
106
729
1.67
4.32
4.9
3.1
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
49
268
1.97
4.25
2.7
2.1
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
115
812
1.64
4.21
7.0
4.8
g/l
36.8
37.0
0.15
110
765
(4010399)
30
137
2.31
4.10
1.6
1.5
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
236
1991
1.66
4.08
5.5
4.3
mmol/mol
37.8
37.9
0.06
225
1880
(3032080) INR in Blood by Coagulation assay
98
669
1.66
4.07
6.2
5.9
inr
1.1
1.1
0.05
27
222
(3000850) Epithelial cells [#/volume] in Urine
68
425
1.76
3.88
3.4
2.5
e6/l
4.5
6.2
0.70
60
371
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
9
15
6.14
3.84
8.9
2.3
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
30
142
2.22
3.78
4.1
4.3
%
0.0
0.6
—
5
36
(3021440) Promyelocytes/100 leukocytes in Blood
31
150
2.18
3.71
4.4
4.8
%
0.2
0.2
—
6
46
(3044941) Cell count panel - Synovial fluid
9
16
5.75
3.68
1.9
1.2
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
30
144
2.19
3.66
4.4
4.9
%
0.0
0.1
—
5
39
(3017181) Myelocytes/100 leukocytes in Blood
32
158
2.14
3.65
4.3
4.7
%
0.3
1.0
—
7
51
(3002582) Erythrocytes [#/volume] in Urine
92
635
1.62
3.61
4.2
3.0
e6/l
12.2
67.0
2.63
71
476
(3022145) Colonoscopy Study observation
40
216
1.97
3.60
1.4
1.4
—
—
—
0
0
(3019060) Gas panel - Arterial blood
22
93
2.46
3.57
6.0
9.1
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
92
637
1.62
3.56
3.4
2.8
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
152
1184
1.53
3.50
3.2
2.7
ug/l
94.3
92.5
0.04
147
1096
(3018095) Leukocytes [#/volume] in Urine
108
789
1.55
3.30
4.8
3.3
e6/l
41.5
58.8
0.23
75
515
(3008898) HLA-B27 [Presence]
24
111
2.25
3.21
1.0
1.1
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
131
1003
1.51
3.20
4.5
4.0
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
81
560
1.59
3.12
5.9
4.1
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
60
388
1.67
3.01
2.4
2.7
ug/g
154.5
143.7
0.07
44
308
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
120
912
1.50
3.00
2.8
2.4
nmol/l
75.6
72.3
0.52
113
840
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
20
88
2.36
3.00
7.2
14.7
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
5
5
10.13
2.99
1.6
1.0
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
257
2285
1.58
2.90
4.8
4.1
mu/l
1.9
1.9
0.01
251
2110
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
16
65
2.54
2.83
2.1
1.6
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
32
175
1.92
2.80
6.8
10.5
mmol/l
0.6
1.0
0.36
25
138
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
18
78
2.38
2.80
1.5
1.6
iu/ml
0.0
0.0
—
5
15
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
125
970
1.47
2.78
9.6
7.6
mmol/l
1.2
1.2
0.65
107
844
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
16
66
2.50
2.75
1.5
1.3
g/l
1.2
1.2
0.11
16
61
(3002173) Hemoglobin [Mass/volume] in Arterial blood
28
148
1.98
2.70
7.1
11.7
g/l
120.8
124.6
0.47
28
143
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
26
134
2.02
2.69
2.6
1.6
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
134
1064
1.44
2.60
6.2
5.8
umol/l
11.9
11.8
0.01
129
1004
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
291
2692
1.72
2.51
13.2
7.9
u/l
27.0
26.4
0.13
286
2600
(36304419) Bacteria [Presence] in Urine
80
579
1.50
2.48
3.8
2.7
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
45
284
1.68
2.48
2.0
1.8
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
82
599
1.49
2.43
2.4
2.4
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
64
444
1.55
2.41
4.4
2.5
umol/l
9541.8
6727.6
0.11
55
398
(3026782) Osmolality of Urine
57
385
1.58
2.40
2.8
2.5
mosm/kgh2o
584.8
579.0
0.06
45
327
(3005570) Glucose [Moles/volume] in Urine
7
17
4.18
2.37
2.7
1.6
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
7
17
4.18
2.37
1.0
1.5
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
6
13
4.68
2.28
3.5
3.9
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
220
1936
1.41
2.26
4.2
3.6
pmol/l
14.4
14.6
0.85
207
1749
(40768797) Stomach Pathology biopsy report
39
244
1.68
2.23
1.0
1.2
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
10
36
2.83
2.22
6.4
2.0
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
67
479
1.50
2.19
4.8
4.0
mg/mmol
15.6
12.3
0.20
46
318
(40758558) Short blood count panel - Blood
83
620
1.45
2.18
11.8
6.7
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
113
894
1.40
2.17
10.7
7.1
mmol/l
1.2
1.2
0.13
106
820
(3019230) Fractional oxyhemoglobin in Venous blood
9
30
3.06
2.16
19.1
3.1
%
74.2
68.0
—
9
30
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
94
722
1.42
2.13
1.6
1.4
u/ml
2.5
1.7
0.24
27
184
(40768443) Skin Pathology biopsy report
16
75
2.19
2.12
1.2
1.2
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
8
25
3.25
2.11
1.1
1.3
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
39
249
1.64
2.07
1.9
1.6
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
24
133
1.87
2.05
1.1
1.2
—
—
—
0
0
(3006245) CD3-CD19+ cells/100 cells in Blood
6
15
4.05
2.05
14.3
2.5
%
11.5
10.2
—
6
15
(3012516) Albumin [Mass/volume] in Urine
63
453
1.48
2.00
4.2
3.3
mg/l
100.5
79.3
0.21
40
301
(3021589) Normoblasts [#/volume] in Blood
139
1150
1.36
2.00
14.0
7.8
e9/l
0.0
0.0
0.32
114
926
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
34
212
1.67
1.98
6.6
5.6
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
29
173
1.74
1.97
2.3
2.4
u/l
11553.3
1521.3
—
6
68
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
5
11
4.60
1.95
5.6
1.9
ug/l
13.9
19.7
—
5
11
(3011648) Oxygen content in Venous blood
6
16
3.80
1.94
27.8
4.3
%
11.0
13.1
—
6
16
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
17
85
2.05
1.94
2.4
2.2
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
17
85
2.05
1.94
7.8
4.1
g/l
0.2
0.3
—
8
47
(3017732) Neutrophils [#/volume] in Blood
27
159
1.76
1.92
2.1
2.3
e9/l
5.8
4.0
1.32
27
137
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
48
330
1.53
1.89
3.3
2.8
ng/l
2203.3
465.9
0.43
32
227
(3007461) Platelets [#/volume] in Blood
313
2996
1.98
1.85
23.4
14.4
e9/l
259.7
257.8
0.23
308
2909
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
71
531
1.43
1.84
2.9
2.2
mg/l
2.4
2.8
0.95
64
437
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
194
1703
1.34
1.83
3.4
2.8
u/l
37.7
36.8
0.07
186
1622
(4024509)
5
12
4.21
1.83
1.2
1.3
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
12
4.21
1.83
1.0
1.0
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
5
12
4.21
1.83
1.0
1.6
mmol/l
1.5
2.1
—
5
12
(3030467) Casts [#/volume] in Urine by Automated count
76
577
1.41
1.82
4.0
2.8
e6/l
0.1
0.3
3.76
58
418
(3015183) Erythrocyte sedimentation rate
7
23
3.09
1.81
1.1
1.2
—
—
—
0
0
(1616796) Gas panel - Central venous blood
8
29
2.80
1.80
5.9
2.8
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
97
769
1.37
1.80
2.3
2.1
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
45
310
1.52
1.76
2.0
2.0
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
50
353
1.49
1.74
3.6
2.5
e6/l
0.6
0.8
0.36
30
199
(3026361) Erythrocytes [#/volume] in Blood
313
3002
1.93
1.74
23.4
14.3
e12/l
4.6
4.6
0.64
307
2909
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
8
30
2.71
1.73
1.1
1.1
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
15
75
2.05
1.72
1.3
2.0
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
5
13
3.89
1.72
1.6
2.2
%
90.7
91.4
—
5
13
(3022621) pH of Urine by Test strip
21
119
1.82
1.70
2.8
2.4
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
313
3004
1.92
1.70
23.5
14.4
e9/l
6.6
6.6
0.03
308
2909
(3003338) MCHC [Mass/volume]
261
2413
1.40
1.67
22.1
12.7
g/l
335.3
334.1
1.40
261
2392
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
7
25
2.84
1.66
1.3
1.8
—
—
—
0
0
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
5
14
3.61
1.62
14.0
2.4
%
33.8
28.2
—
5
14
(3013512) EKG study
65
491
1.40
1.60
3.0
2.9
—
—
—
0
0
(4062490)
6
20
3.04
1.59
1.7
1.1
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
24
146
1.69
1.55
2.0
2.6
ml/min/173m2
79.6
76.7
—
9
64
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
241
2211
1.34
1.54
3.8
3.6
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
5
15
3.37
1.53
2.0
3.6
nmol/l
2.7
2.9
—
5
15
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
7
27
2.63
1.52
3.3
1.7
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
6
21
2.89
1.51
1.0
1.1
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
6
21
2.89
1.51
1.5
2.0
mmol/l
1.3
1.7
—
6
21
(3018418) pH of Serum or Plasma
74
579
1.36
1.48
5.1
3.9
ph
7.4
7.4
0.84
11
99
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
51
375
1.43
1.46
2.1
2.1
—
—
—
0
0
(44790047)
7
28
2.53
1.46
3.4
1.5
—
—
—
0
0
(44790048)
7
28
2.53
1.46
3.4
1.5
—
—
—
0
0
(44806118)
7
28
2.53
1.46
3.4
1.5
—
—
—
0
0
(44790049)
7
28
2.53
1.46
3.4
1.5
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
13
66
2.01
1.45
7.6
2.7
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
5
16
3.16
1.44
1.8
1.3
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
6
22
2.76
1.44
3.7
1.9
—
—
—
0
0
(3019225) pH of Specimen
25
158
1.63
1.42
3.8
4.1
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
10
46
2.21
1.41
1.2
1.1
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
87
703
1.32
1.40
1.5
1.7
pmol/l
95.9
94.4
0.11
47
381
(3044889) 12 lead EKG panel
167
1472
1.27
1.38
3.1
2.9
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
10
47
2.16
1.35
2.8
1.9
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
27
177
1.57
1.34
25.1
11.8
inr
1.1
1.2
—
10
36
(3013139) Helicobacter pylori Ag [Presence] in Stool
21
129
1.67
1.33
1.0
1.2
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
6
24
2.53
1.31
1.0
1.2
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
97
804
1.29
1.29
1.9
1.7
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
5
18
2.80
1.29
8.8
7.4
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
8
35
2.32
1.27
3.0
1.9
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
29
196
1.53
1.27
2.1
1.7
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
48
359
1.39
1.26
1.6
1.7
pmol/l
393.3
12579056.3
0.50
43
318
(3021901) Oxygen saturation in Capillary blood
8
36
2.25
1.25
1.5
8.8
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
8
36
2.25
1.25
22.0
3.4
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
10
49
2.07
1.23
1.8
1.3
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
99
829
1.28
1.21
1.6
1.9
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
40
293
1.42
1.19
4.7
2.2
s
27.8
29.8
2.42
40
284
(3023511) Choriogonadotropin [Units/volume] in Urine
18
110
1.67
1.18
1.8
1.2
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
10
50
2.03
1.17
2.7
1.8
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
15
87
1.76
1.17
1.2
1.3
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
37
268
1.43
1.17
1.3
1.2
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
5
20
2.52
1.15
1.4
1.9
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
0
36
0.00
1.14
0.0
3.8
—
18.3
—
0
36
(3003327) Ova and parasites identified in Stool by Light microscopy
16
96
1.70
1.12
1.9
1.5
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
33
236
1.44
1.12
14.3
4.8
mmol/l
1.8
1.6
0.17
28
186
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
237
2207
1.27
1.12
4.2
3.4
mmol/l
5.7
5.6
0.29
227
2036
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
22
144
1.57
1.12
1.3
1.9
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
25
169
1.52
1.11
3.0
7.4
mmol/l
1.7
1.6
0.10
19
121
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
24
161
1.53
1.10
4.8
3.3
pmol/l
4.9
4.7
0.45
24
147
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
27
186
1.49
1.10
6.9
4.3
u/l
235.1
232.2
0.07
27
179
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
5
21
2.40
1.09
1.0
1.5
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
28
195
1.48
1.09
2.3
1.8
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
13
74
1.79
1.08
2.7
1.8
—
—
—
0
0
(3012544) pH of Venous blood
33
238
1.43
1.08
14.5
4.8
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
51
397
1.34
1.06
2.0
1.6
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
33
2.15
1.06
1.1
1.8
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
270
2562
1.30
1.05
18.6
10.8
%
39.2
40.6
1.55
209
2078
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
43
327
1.36
1.04
3.7
2.7
e6/l
1.3
2.6
1.15
23
175
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
5
22
2.29
1.03
1.2
1.0
—
—
—
0
0
(3013290) Carbon dioxide [Partial pressure] in Blood
7
34
2.08
1.03
6.4
2.5
kpa
5.1
5.0
—
7
34
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
7
34
2.08
1.03
3.7
1.9
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
7
34
2.08
1.03
6.4
2.5
kpa
9.4
9.0
—
7
34
(3014007) Fractional oxyhemoglobin in Arterial blood
16
99
1.65
1.02
6.6
10.5
%
92.7
94.6
0.50
16
99
(3030905) Polymorphonuclear cells [#/volume] in Blood
7
35
2.02
1.00
3.1
3.1
e9/l
2.5
3.6
—
7
35
(40761511) CBC panel - Blood by Automated count
285
2730
1.34
0.98
12.9
8.8
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
5
23
2.19
0.98
1.0
1.3
mu/l
43.8
28.5
—
5
23
(4268621)
0
30
0.00
0.97
0.0
1.9
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
7
36
1.96
0.97
3.1
3.3
%
50.7
52.4
—
7
36
(3044640) Blood type and Crossmatch panel - Blood
79
661
1.26
0.97
2.9
2.1
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
13
77
1.72
0.96
1.4
1.3
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
237
2224
1.24
0.95
10.5
8.7
ml/min/173m2
94.5
93.0
0.38
186
1722
(3021387) Prolactin [Units/volume] in Serum or Plasma
21
142
1.51
0.95
1.2
1.5
mu/l
269.5
327.7
0.73
21
133
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
7
37
1.91
0.94
2.1
1.3
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
78
654
1.25
0.94
1.7
1.5
g/l
2.0
2.1
0.27
50
395
(40761536) Microorganisms panel - Urine sediment
27
193
1.43
0.94
3.0
3.0
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
6
27
2.24
0.94
1.0
1.1
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
6
27
2.24
0.94
11.3
2.3
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
62
506
1.28
0.93
2.9
2.0
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
28
202
1.42
0.93
1.1
1.3
iu/ml
47.2
147.0
2.26
14
91
(3024354) Oxygen [Partial pressure] in Venous blood
29
211
1.41
0.92
15.3
4.4
kpa
5.5
4.8
0.77
29
206
(3021879) Hepatitis B virus core Ab [Presence] in Serum
34
257
1.36
0.87
1.6
1.5
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
8
44
1.84
0.86
3.0
2.3
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
58
475
1.27
0.85
1.6
1.5
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
25
180
1.42
0.85
16.7
8.3
mmol/l
24.8
25.1
0.29
25
180
(3016879) Cocaine [Presence] in Urine
18
259
0.68
0.84
2.4
1.8
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
22
155
1.45
0.83
4.9
5.1
ng/l
64.8
71.2
0.24
22
145
(21494755) Public health laboratory ask at order entry panel
42
331
1.31
0.83
1.3
1.3
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
6
32
1.89
0.82
1.5
1.2
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
0
26
0.00
0.78
0.0
1.7
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
0
27
0.00
0.78
0.0
1.0
—
1.4
—
0
22
(3019309) Folate [Moles/volume] in Red Blood Cells
36
281
1.32
0.77
1.5
1.6
nmol/l
1113.6
1149.0
0.06
31
219
(3028626) Oxygen [Partial pressure] in Capillary blood
17
116
1.49
0.76
3.4
8.5
kpa
8.8
9.3
0.59
17
105
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
16
108
1.51
0.75
1.4
1.4
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
5
24
2.10
0.75
13.0
2.1
—
—
—
0
0
(1002224) Polysomnography panel
14
92
1.55
0.73
1.0
1.1
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
231
2187
1.19
0.73
4.2
3.2
mmol/l
1.3
1.2
0.35
225
2057
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
21
284
0.72
0.71
1.6
1.5
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
7
41
1.72
0.70
1.0
1.2
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
7
43
1.64
0.67
1.1
1.3
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
13
86
1.53
0.67
1.3
1.1
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
5
28
1.80
0.66
2.4
1.6
%
13.2
12.7
—
5
28
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
11
70
1.59
0.66
1.2
1.8
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
239
2278
1.18
0.65
4.3
3.4
mmol/l
1.4
1.5
0.37
232
2143
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
7
44
1.60
0.65
1.4
1.4
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
40
325
1.26
0.65
4.1
3.9
%
22.0
21.2
0.14
19
145
(3000991) Gas panel - Venous blood
27
208
1.32
0.64
12.9
8.3
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
13
87
1.51
0.64
1.5
1.5
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
5
29
1.74
0.64
1.0
1.1
—
—
—
0
0
(3020891) Body temperature
10
63
1.61
0.62
4.5
4.0
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
8
50
1.61
0.61
1.1
1.1
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
240
2294
1.17
0.61
4.4
3.5
mmol/l
4.7
4.7
0.29
233
2168
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
12
80
1.52
0.60
1.2
1.3
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
68
591
1.19
0.59
2.2
1.7
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
64
554
1.19
0.58
1.8
1.7
mmol/l
1.3
1.3
0.09
58
481
(4034850)
11
73
1.52
0.57
23.0
6.6
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
6
37
1.63
0.56
1.0
1.3
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
22
282
0.76
0.55
2.2
1.8
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
9
61
1.49
0.54
1.0
1.3
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
6
39
1.55
0.53
2.0
2.5
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
10
66
1.53
0.53
1.4
1.2
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
22
280
0.77
0.52
2.2
1.7
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
32
261
1.25
0.52
1.5
1.6
—
—
—
0
0
(4094501)
6
40
1.51
0.52
1.0
1.1
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
22
279
0.77
0.51
2.2
1.7
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
241
2317
1.15
0.51
4.6
3.7
mmol/l
2.8
2.8
0.30
234
2173
(3027944) Amphetamines [Presence] in Urine
22
278
0.78
0.50
2.2
1.8
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
16
211
0.75
0.49
2.4
1.9
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
7
45
1.57
0.49
1.9
2.5
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
7
46
1.53
0.48
1.3
1.4
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
15
198
0.75
0.47
1.5
1.3
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
12
87
1.39
0.43
1.7
1.9
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
5
32
1.57
0.42
1.2
1.2
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
5
33
1.52
0.41
1.0
2.9
mmol/l
8.9
7.3
—
5
33
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method
0
16
0.00
0.41
0.0
2.3
—
0.1
—
0
11
(4281824)
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
8
60
1.34
0.40
1.1
1.4
—
65.6
—
0
9
(3008037) Lactate [Moles/volume] in Venous blood
5
34
1.48
0.40
1.0
2.9
mmol/l
1.9
1.5
—
5
34
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
23
187
1.25
0.40
1.0
1.1
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
54
478
1.16
0.40
2.0
1.8
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
18
142
1.28
0.39
3.3
3.8
mmol/l
1.2
1.2
0.32
13
122
(3011288) Drugs identified in Urine by Screen method
15
192
0.77
0.39
4.3
2.2
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
9
67
1.35
0.38
1.8
2.0
ug/l
0.4
0.7
—
9
60
(3015377) Calcium [Moles/volume] in Serum or Plasma
75
683
1.13
0.37
3.2
3.3
mmol/l
2.3
2.4
1.46
69
626
(3014051) Protein [Presence] in Urine by Test strip
5
37
1.36
0.37
2.6
2.2
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
9
70
1.29
0.37
2.3
1.5
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
6
42
1.44
0.35
1.2
1.1
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
9
125
0.71
0.35
1.8
1.3
—
—
—
0
0
(3002256) Pathology report gross observation
21
254
0.81
0.35
1.2
1.2
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
11
82
1.35
0.34
1.2
1.3
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
13
100
1.31
0.34
1.8
1.6
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
25
211
1.20
0.32
1.4
1.3
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
19
156
1.23
0.31
1.3
1.6
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
7
54
1.30
0.30
1.3
1.2
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
11
84
1.32
0.30
36.4
8.3
mg/l
1.2
1.2
0.10
11
79
(3036489) Thrombin time
8
106
0.75
0.29
12.4
2.4
s
19.5
21.8
—
8
100
(1761868) Lipid panel - Serum or Plasma
85
911
0.91
0.29
2.8
2.3
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
21
177
1.20
0.28
1.5
1.4
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
10
128
0.77
0.27
1.5
1.5
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
20
169
1.20
0.26
1.4
1.2
titre
—
8.0
—
0
5
(3014765) Yersinia sp identified in Stool by Organism specific culture
9
74
1.22
0.25
1.0
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
9
74
1.22
0.25
1.0
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
9
74
1.22
0.25
1.0
1.1
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
11
87
1.27
0.24
1.6
1.6
u/ml
158.8
203.5
—
6
46
(3023183) Ammonium ion [Moles/volume] in Plasma
5
41
1.22
0.22
1.4
3.6
umol/l
27.2
39.7
—
5
36
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
5
42
1.19
0.21
1.2
1.0
—
—
—
0
0
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.1
—
5.8
—
0
11
(3024932) HLA-DR beta [Type]
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3024471) HLA-A [Type]
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3000012) Reticulocyte production index
0
10
0.00
0.21
0.0
1.9
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
11
89
1.24
0.21
1.0
1.2
u/ml
0.4
2.2
—
6
44
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
0
13
0.00
0.21
0.0
1.2
—
98.4
—
0
13
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(40768441) Liver Pathology biopsy report
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
6
48
1.25
0.20
1.0
1.2
—
4.4
—
0
8
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
6
48
1.25
0.20
1.0
1.2
—
10.8
—
0
10
(3016650) Hepatitis A virus Ab [Presence] in Serum
6
49
1.23
0.20
1.2
1.0
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
11
91
1.22
0.18
1.5
1.6
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
11
130
0.84
0.16
1.1
1.6
mg/l
2.5
2.6
—
6
85
(3024891) Influenza virus A+B Ag [Presence] in Specimen
6
77
0.78
0.16
2.7
1.1
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
41
381
1.09
0.15
4.6
3.3
ng/l
1975.5
891.0
0.45
36
304
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
10
83
1.21
0.15
3.1
3.3
%
52.7
53.5
—
10
83
(3043238) Trisomy 21 risk [Likelihood] in Fetus
8
96
0.83
0.14
1.6
1.5
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
20
180
1.12
0.13
2.8
2.9
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
13
113
1.16
0.13
2.1
1.5
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
10
85
1.18
0.12
1.6
1.7
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
18
163
1.11
0.11
2.1
1.6
iu/l
22.9
18.6
0.22
18
139
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
5
45
1.11
0.10
1.2
3.4
—
0.3
—
0
25
(3022313) Gas panel - Capillary blood
16
145
1.11
0.09
3.8
7.3
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
47
450
1.05
0.08
1.5
1.4
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
7
67
1.05
0.08
1.9
1.4
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
7
68
1.03
0.08
1.0
1.3
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
10
112
0.89
0.07
1.5
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
10
112
0.89
0.07
1.5
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
10
112
0.89
0.07
1.5
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
10
112
0.89
0.07
1.5
1.4
—
—
—
0
0
(3000492) Spirometry study
20
214
0.93
0.07
1.6
1.3
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
11
122
0.90
0.07
1.5
2.0
u/ml
15.4
34.6
1.52
11
117
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
9
88
1.02
0.07
1.8
1.8
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
10
89
1.13
0.07
2.2
3.1
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
8
94
0.85
0.07
1.6
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
8
94
0.85
0.07
1.6
1.4
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
16
149
1.08
0.05
1.4
1.4
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
23
220
1.05
0.03
3.3
3.3
%
33.1
31.2
0.35
16
147
(3003694) ABO and Rh group [Type] in Blood
76
773
0.98
0.03
1.4
1.6
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
27
260
1.04
0.03
1.6
1.9
—
—
—
0
0
(4035726)
17
161
1.06
0.03
1.5
1.4
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
20
191
1.05
0.03
3.2
2.9
g/l
0.2
0.2
0.21
20
178
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
23
222
1.04
0.02
1.6
1.5
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
15
143
1.05
0.01
2.0
1.7
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
66
654
1.01
0.00
2.9
2.4
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
23
233
0.99
0.00
2.3
2.7
ug/l
0.7
0.8
0.04
15
148
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
60
604
0.99
0.00
2.8
2.2
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3003633) Ovomucoid IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
2.4
—
4.2
—
0
5
(3043410) Blood group antigens tested for on Red Blood Cells
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3034426) Prothrombin time (PT)
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
0
9
0.00
0.00
0.0
3.8
—
128.7
—
0
9
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
0
5
0.00
0.00
0.0
1.6
—
13.1
—
0
5
(3013336) Amino acids [Identifier] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool
0
5
0.00
0.00
0.0
1.6
—
144.0
—
0
5
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
5
0.00
0.00
0.0
3.2
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3013247) Albumin in CSF/Albumin in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
11.4
—
0
6
(3004588) Protein electrophoresis panel - Serum or Plasma
7
75
0.93
0.00
1.3
2.7
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.8
—
0.9
—
0
9
(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
1.7
—
0
6
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
0
9
0.00
0.00
0.0
4.9
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004593) Baker's yeast IgA Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3010015) Selenium [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.6
—
1.2
—
0
7
(3028707) Methadone [Presence] in Urine by Screen method
12
120
1.00
0.00
2.6
2.3
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint M13_TRANSSYNOVITIS and mortality.

Females

Parameter HR [95% CI] p-value
M13_TRANSSYNOVITIS 1.188 [0.89, 1.59] 0.244
Birth year 0.993 [0.98, 1.0] 0.098

During the follow-up period (1.1.1998 — 31.12.2019), 53 out of 1551 females with M13_TRANSSYNOVITIS died.

Males

Parameter HR [95% CI] p-value
M13_TRANSSYNOVITIS 1.195 [0.91, 1.56] 0.196
Birth year 0.989 [0.98, 1.0] 0.024

During the follow-up period (1.1.1998 — 31.12.2019), 71 out of 2694 males with M13_TRANSSYNOVITIS died.

Mortality risk

Mortality risk for people of age

years, who have M13_TRANSSYNOVITIS.

N-year risk Females Males
1 0.096% 0.247%
5 0.579% 1.482%
10 1.456% 3.667%
15 2.989% 7.022%
20 5.127% 11.837%

Relationships between endpoints

↥

Index endpoint: M13_TRANSSYNOVITIS – Transient synovitis

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data